Concepedia

Estimated GFR Decline as a Surrogate End Point for Kidney Failure: A Post Hoc Analysis From the Reduction of End Points in Non–Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan (RENAAL) Study and Irbesartan Diabetic Nephropathy Trial (IDNT)

Hiddo J.L. Heerspink, Misghina Weldegiorgis, Lesley A. Inker, Ron T. Gansevoort, Hans‐Henrik Parving, Jamie P. Dwyer, Hasi Mondal, Josef Coresh, Tom Greene, Andrew S. Levey,

American Journal of Kidney Diseases · 2013 · 67 citations · 14 references

DOI

Concepts

References

14

A New Equation to Estimate Glomerular Filtration Rate

Andrew S. Levey, Lesley A. Stevens, Christopher H. Schmid et al. · Annals of Internal Medicine · 2009 · 25.7K citations

, , +12

Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy

Barry M. Brenner, Mark E. Cooper, Dick de Zeeuw et al. · New England Journal of Medicine · 2001 · 7.5K citations · Full text

, , +17

Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes

Edmund J. Lewis, Lawrence G. Hunsicker, William R. Clarke et al. · New England Journal of Medicine · 2001 · 6K citations · Full text

, , +16

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial

Anushka Patel · The Lancet · 2007 · 2.1K citations

, , +13

Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass.

Sharon Anderson, Timothy W. Meyer, Helmut G. Rennke et al. · Journal of Clinical Investigation · 1985 · 942 citations · Full text

, , +17